The Closed System Drug Transfer Device Market includes a range of technologies and product configurations designed to improve the safety of hazardous drug preparation and administration. The market is segmented by system type, component, closing mechanism, technology, end user, and region. Market Research Future projects a 13.6% CAGR for the market during the forecast period to 2035.

Needleless systems represent a major portion of demand because they combine drug containment with sharps-injury prevention. Membrane-to-membrane systems are also gaining attention, particularly in high-volume compounding facilities. Among components, vial access devices represent an important category because they are used at the beginning of many closed-transfer workflows.

By technology, diaphragm-based devices currently hold a leading position because of their established containment capabilities. Compartmentalized technologies are also developing as healthcare facilities manage increasingly diverse medication portfolios. Closing mechanisms include luer-lock, push-to-turn, color-to-color alignment, and click-to-lock systems, each addressing different workflow and usability requirements.

Hospitals remain the dominant end-user group because they are major locations for chemotherapy preparation and administration. Oncology centers are another rapidly developing segment as specialized cancer-care facilities expand.

Technological development is expected to remain central to market growth. Manufacturers are focusing on ergonomic designs, improved connectors, automation compatibility, and digital tracking. These innovations could help healthcare providers improve safety while maintaining efficient medication-preparation workflows.